Status:
COMPLETED
Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Advance Care Planning
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall goal of this study is to identify the most effective and efficient advance care planning (ACP) strategy for patients with advanced cancer. The specific aims are to: Aim 1. Compare the ef...
Detailed Description
Study investigators will conduct a single-blind, patient-level randomized trial to compare the effectiveness of two different patient-facing advance care planning (ACP) interventions. Investigators wi...
Eligibility Criteria
Inclusion
- Patient
- 18 years of age or older
- Solid tumor
- The oncologist "would not be surprised" if the patient died within the next year
- Eastern Cooperative Oncology Group performance status (ECOG PS) of 0, 1, or 2
- Planning to receive ongoing care at a participating oncology clinic
- Willing to participate in either a web-based or facilitated program
- Patient
Exclusion
- Does not speak English
- Inability to consent, using a validated teach-back method
- Hematologic malignancy
- No phone for additional study contacts and follow-up interviews
- Unable to participate in advance care planning, as assessed by clinician
- Unable to complete the baseline interview
- Patients will be able to identify and enroll a caregiver, designated by the patient as the primary family member or friend involved in their care and best able to participate in the study.
- Caregiver Inclusion criteria:
- 18 years of age or older
- Family member or friend of an eligible patient
- Primary person involved in patient's care and best able to participate in the study, as assessed by patient
- Caregiver Exclusion criteria:
- Does not speak English
- No phone for additional study contacts and follow-up interviews
- Unable to complete the baseline interview
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2025
Estimated Enrollment :
672 Patients enrolled
Trial Details
Trial ID
NCT03824158
Start Date
August 1 2019
End Date
July 30 2025
Last Update
August 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, United States, 15232